Lee Ainslie - Maverick Capital
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 68,779 | 0.02 | Add 5.03% | 0.00 | $18.01 |
| 2024 Q2 | 65,483 | 0.02 | Add 13.79% | 0.00 | $16.25 |
| 2024 Q1 | 57,545 | 0.02 | Reduce 8.73% | 0.00 | $14.11 |
| 2023 Q4 | 63,047 | 0.01 | Add 90.45% | 0.00 | $10.44 |
| 2023 Q3 | 33,105 | 0.01 | Reduce 34.56% | 0.01 | $10.21 |
| 2023 Q2 | 50,588 | 0.01 | Reduce 4.31% | 0.00 | $7.53 |
| 2023 Q1 | 52,865 | 0.01 | Add 68.10% | 0.00 | $8.85 |
| 2022 Q4 | 31,449 | 0.01 | Buy | 0.01 | $9.13 |
| 2021 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2021 Q2 | 44,879 | 0.00 | Reduce 71.20% | 0.00 | $9.89 |
| 2021 Q1 | 155,841 | 0.02 | Add 248.84% | 0.01 | $11.54 |
| 2020 Q4 | 44,674 | 0.01 | Reduce 64.31% | 0.02 | $9.65 |
| 2020 Q3 | 125,177 | 0.02 | Buy | 0.02 | $9.01 |
| 2020 Q1 | 0 | 0 | Sell 100.00% | 0.07 | |
| 2019 Q4 | 461,715 | 0.07 | Reduce 30.17% | 0.03 | $9.80 |
| 2019 Q3 | 661,215 | 0.07 | Buy | 0.07 | $6.88 |
| 2019 Q2 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2019 Q1 | 94,530 | 0.02 | Reduce 60.81% | 0.03 | $15.68 |
| 2018 Q4 | 241,220 | 0.05 | Buy | 0.05 | $15.42 |